International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

Comparison of the Efficacy of Topical Tacrolimus and Pimecrolimus in Treatment of Stable Vitiligo

Yazarlar: Yashwant Anant Lal, Shankar K

Cilt 4 , Sayı 18 , 2021 , Sayfalar 85-90

Konular:-

Anahtar Kelimeler:Tacrolimus,Pimecrolimus,& Vitiligo

Özet: Background: The topical calcineurin inhibitors (TCIs) are emerging treatment modalities for vitiligo patients. Aim and objective: The aim of this study was to assess the efficacy and tolerability of the TCIs Tacrolimus and Pimecrolimus in vitiligo patients. Methods: A total of 40 patients with vitiligo were enrolled in this study. They were divided into two groups: topical Tacrolimus 0.1% ointment(20) and topical Pimecrolims 1% cream(20). The efficacy of treatment was assessed 2,4,8,12 and 24 weeks. Results: At the end of 24th week, Tacrolimus users showed 25% repigmentation with score of repigmentation 2.62 whereas Pimecrolimus users showed 20% repigmentation with score of repigmentation 2.02. Conclusion: After 24 weeks, Tacrolimus 0.1% users showed more efficacy comparing Pimecrolimus 1% topical drug users.

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2021, title={Comparison of the Efficacy of Topical Tacrolimus and Pimecrolimus in Treatment of Stable Vitiligo}, volume={4}, number={85–90}, publisher={International Journal of Health and Clinical Research}, author={Yashwant Anant Lal,Shankar K}, year={2021} }
APA
KOPYALA
Yashwant Anant Lal,Shankar K. (2021). Comparison of the Efficacy of Topical Tacrolimus and Pimecrolimus in Treatment of Stable Vitiligo (Vol. 4). Vol. 4. International Journal of Health and Clinical Research.
MLA
KOPYALA
Yashwant Anant Lal,Shankar K. Comparison of the Efficacy of Topical Tacrolimus and Pimecrolimus in Treatment of Stable Vitiligo. no. 85–90, International Journal of Health and Clinical Research, 2021.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri